183 related articles for article (PubMed ID: 10413042)
1. Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators.
Loyevsky M; John C; Dickens B; Hu V; Miller JH; Gordeuk VR
Mol Biochem Parasitol; 1999 Jun; 101(1-2):43-59. PubMed ID: 10413042
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures.
Loyevsky M; Sacci JB; Boehme P; Weglicki W; John C; Gordeuk VR
Exp Parasitol; 1999 Feb; 91(2):105-14. PubMed ID: 9990337
[TBL] [Abstract][Full Text] [Related]
3. Mode of action of iron (III) chelators as antimalarials: I. Membrane permeation properties and cytotoxic activity.
Lytton SD; Mester B; Dayan I; Glickstein H; Libman J; Shanzer A; Cabantchik ZI
Blood; 1993 Jan; 81(1):214-21. PubMed ID: 8417790
[TBL] [Abstract][Full Text] [Related]
4. Iron chelators: mode of action as antimalarials.
Cabantchik ZI; Glickstein H; Golenser J; Loyevsky M; Tsafack A
Acta Haematol; 1996; 95(1):70-7. PubMed ID: 8604590
[TBL] [Abstract][Full Text] [Related]
5. Malaria pigment and extracellular iron. Possible target for iron chelating agents.
van Zyl RL; Havlik I; Hempelmann E; MacPhail AP; McNamara L
Biochem Pharmacol; 1993 Apr; 45(7):1431-6. PubMed ID: 8471067
[TBL] [Abstract][Full Text] [Related]
6. Anti-plasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron pool.
Walcourt A; Kurantsin-Mills J; Kwagyan J; Adenuga BB; Kalinowski DS; Lovejoy DB; Lane DJ; Richardson DR
J Inorg Biochem; 2013 Dec; 129():43-51. PubMed ID: 24028863
[TBL] [Abstract][Full Text] [Related]
7. Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II).
Breuer W; Epsztejn S; Cabantchik ZI
J Biol Chem; 1995 Oct; 270(41):24209-15. PubMed ID: 7592626
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria.
Pattanapanyasat K; Thaithong S; Kyle DE; Udomsangpetch R; Yongvanitchit K; Hider RC; Webster HK
Cytometry; 1997 Jan; 27(1):84-91. PubMed ID: 9000589
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of novel iron chelator, 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) and green tea extract on growth of Plasmodium falciparum.
Thipubon P; Uthaipibull C; Kamchonwongpaisan S; Tipsuwan W; Srichairatanakool S
Malar J; 2015 Sep; 14():382. PubMed ID: 26424148
[TBL] [Abstract][Full Text] [Related]
10. Parasite uptake of desferroxamine: a prerequisite for antimalarial activity.
Scott MD; Ranz A; Kuypers FA; Lubin BH; Meshnick SR
Br J Haematol; 1990 Aug; 75(4):598-602. PubMed ID: 1698449
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium falciparum: inhibition in vitro with lactoferrin, desferriferrithiocin, and desferricrocin.
Fritsch G; Sawatzki G; Treumer J; Jung A; Spira DT
Exp Parasitol; 1987 Feb; 63(1):1-9. PubMed ID: 3542546
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial activity of selected aromatic chelators V. Localization of 59Fe in Plasmodium falciparum in the presence of oxines.
Scheibel LW; Rodriguez S
Prog Clin Biol Res; 1989; 313():119-49. PubMed ID: 2506579
[No Abstract] [Full Text] [Related]
13. 14C-desferrioxamine B: uptake into erythrocytes infected with Plasmodium falciparum.
Fritsch G; Jung A
Z Parasitenkd; 1986; 72(6):709-13. PubMed ID: 3541423
[TBL] [Abstract][Full Text] [Related]
14. The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites.
Loyevsky M; Lytton SD; Mester B; Libman J; Shanzer A; Cabantchik ZI
J Clin Invest; 1993 Jan; 91(1):218-24. PubMed ID: 8423220
[TBL] [Abstract][Full Text] [Related]
15. Reversed siderophores as antimalarial agents. II. Selective scavenging of Fe(III) from parasitized erythrocytes by a fluorescent derivative of desferal.
Lytton SD; Cabantchik ZI; Libman J; Shanzer A
Mol Pharmacol; 1991 Oct; 40(4):584-90. PubMed ID: 1921988
[TBL] [Abstract][Full Text] [Related]
16. Aminothiol multidentate chelators as antimalarials.
Loyevsky M; John C; Zaloujnyi I; Gordeuk V
Biochem Pharmacol; 1997 Aug; 54(4):451-8. PubMed ID: 9313771
[TBL] [Abstract][Full Text] [Related]
17. Determination of the chelatable iron pool of isolated rat hepatocytes by digital fluorescence microscopy using the fluorescent probe, phen green SK.
Petrat F; Rauen U; de Groot H
Hepatology; 1999 Apr; 29(4):1171-9. PubMed ID: 10094962
[TBL] [Abstract][Full Text] [Related]
18. Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells.
Glickstein H; Breuer W; Loyevsky M; Konijn AM; Shanzer A; Cabantchik ZI
Blood; 1996 Jun; 87(11):4871-8. PubMed ID: 8639861
[TBL] [Abstract][Full Text] [Related]
19. The biochemical basis for the selective antimalarial action of iron chelators on Plasmodium falciparum parasitized cells.
Lytton SD; Loyevsky M; Libman J; Mester B; Shanzer A; Cabantchik ZI
Adv Exp Med Biol; 1994; 356():385-97. PubMed ID: 7887244
[No Abstract] [Full Text] [Related]
20. Mode of action of iron (III) chelators as antimalarials: II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis.
Lytton SD; Mester B; Libman J; Shanzer A; Cabantchik ZI
Blood; 1994 Aug; 84(3):910-5. PubMed ID: 8043872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
